Icarus
Active member
I have just found this statement from AstraZeneca regarding Exanta. I hope it means it's being released in the USA next year.
"Exanta, the oral anticoagulant - major indications on track - filing for first indication in prevention of venous thromboembolism (VTE) expected Q3 2002 (EU)/ Q2 2003 (US); stroke prevention filing expected Q2 2003 (EU/US"
However, does anyone know what they mean by "filing for first indication"?
Icarus
"Exanta, the oral anticoagulant - major indications on track - filing for first indication in prevention of venous thromboembolism (VTE) expected Q3 2002 (EU)/ Q2 2003 (US); stroke prevention filing expected Q2 2003 (EU/US"
However, does anyone know what they mean by "filing for first indication"?
Icarus